Home About Cancer News Contact Cancer News
Home About Cancer News Contact Cancer News
Twitter

Archive for April 26th, 2012

« Older Entries

Prospective Random Comparing Study on EUS-guided Pseudocyst Drainage by Naso-pancreatic Tube and Stents

By on Thursday, April 26th, 2012 | No Comments

Condition :   Pancreatic Pseudocyst Intervention :   Procedure: EUS-guided pancreatic pseudocyst drainage Sponsors :   Fourth Military Medical University;   Xiaoyin Zhang Recruiting – verified April 2012

Read More...

Phase I/II Study of hLL1-DOX in Relapsed NHL and CLL

By on Thursday, April 26th, 2012 | No Comments

Conditions :   Non-Hodgkin’s Lymphoma;   Chronic Lymphocytic Leukemia Intervention :   Drug: hLL1-DOX (IMMU-115) Sponsors :   Immunomedics, Inc.;   Immunomedics, Inc. Not yet recruiting – verified April 2012

Read More...

Human Placental-Derived Stem Cell Transplantation

By on Thursday, April 26th, 2012 | No Comments

Conditions :   Mucopolysaccharidosis I;   Mucopolysaccharidosis VI;   Adrenoleukodystrophy;   Niemann-Pick Disease;   Metachromatic Leukodystrophy;   Wolman Disease;   Krabbe’s Disease;   Gaucher’s Disease;   Fucosidosis;   Batten Disease;   Severe Aplastic Anemia;   Diamond-Blackfan Anemia;   Amegakaryocytic Thrombocytopenia;   Myelodysplastic Syndrome;   Acute Myelogenous Leukemia;   Acute Lymphocytic Leukemia Intervention :   Drug: Human Placental Derived Stem Cell Sponsors :   New York Medical College;   New York Medical College Not yet recruiting – verified April 2012

Read More...

Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of Sorafenib and Eribulin in Combination

By on Thursday, April 26th, 2012 | No Comments

Condition :   Breast Neoplasms Interventions :   Drug: Sorafenib (Nexavar, BAY43-9006);   Drug: Eribulin Sponsors :   Bayer;   Bayer Not yet recruiting – verified April 2012

Read More...

Study Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutations Other Than V600E

By on Thursday, April 26th, 2012 | No Comments

Condition :   Malignant Melanoma Intervention :   Drug: Zelboraf (vemurafenib) Sponsors :   Genentech;   Genentech Recruiting – verified April 2012

Read More...

Drug Interaction Study of SAR302503 in Patients With Solid Tumor

By on Thursday, April 26th, 2012 | No Comments

Condition :   Solid Tumor Interventions :   Drug: SAR302503;   Drug: omeprazol;   Drug: metoprolol;   Drug: midazolam Sponsors :   Sanofi-Aventis;   Sanofi-Aventis Not yet recruiting – verified April 2012

Read More...

Transfer of Genetically Engineered Lymphocytes in Melanoma Patients

By on Thursday, April 26th, 2012 | No Comments

Condition :   Melanoma Interventions :   Biological: Dose 1;   Biological: Dose 2;   Biological: Dose 3;   Biological: Dose 4 Sponsors :   Loyola University;   Loyola University;   National Cancer Institute (NCI) Not yet recruiting – verified April 2012

Read More...

Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Patients With Brain Tumors

By on Thursday, April 26th, 2012 | No Comments

Conditions :   Adult Anaplastic Astrocytoma;   Adult Anaplastic Ependymoma;   Adult Anaplastic Meningioma;   Adult Anaplastic Oligodendroglioma;   Adult Brain Stem Glioma;   Adult Choroid Plexus Tumor;   Adult Craniopharyngioma;   Adult Diffuse Astrocytoma;   Adult Ependymoblastoma;   Adult Ependymoma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Grade I Meningioma;   Adult Grade II Meningioma;   Adult Medulloblastoma;   Adult Meningeal Hemangiopericytoma;   Adult Mixed Glioma;   Adult Myxopapillary Ependymoma;   Adult Oligodendroglioma;   Adult Papillary Meningioma;   Adult Pilocytic Astrocytoma;   Adult Pineal Gland Astrocytoma;   Adult Pineoblastoma;   Adult Pineocytoma;   Adult Subependymal Giant Cell Astrocytoma;   Adult Subependymoma;   Adult Supratentorial Primitive Neuroectodermal Tumor (PNET);   Meningeal Melanocytoma;   Nonmalignant Neoplasm;   Recurrent Adult Brain Tumor;   Tumors Metastatic to Brain Interventions :   Drug: pioglitazone hydrochloride;   Other: laboratory biomarker analysis;   Radiation: external beam radiation therapy;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy;   Procedure: management of therapy complications Sponsors :   Comprehensive Cancer Center of Wake Forest University;   Comprehensive Cancer Center of Wake Forest University;   National Cancer Institute (NCI) Recruiting – verified April 2012

Read More...

Specimen Banking From Patients With Lung Cancer

By on Thursday, April 26th, 2012 | No Comments

Condition :   Lung Neoplasms Intervention :   Sponsors :   University of Colorado, Denver;   University of Colorado, Denver;   National Cancer Institute (NCI) Recruiting – verified April 2012

Read More...

PK/PD of XM22 in Children With Ewing Family of Tumors or Rhabdomyosarcoma

By on Thursday, April 26th, 2012 | No Comments

Condition :   Ewing Family of Tumors, Rhabdomyosarcoma Intervention :   Drug: Lipegfilgrastim Sponsors :   Teva Pharmaceutical Industries;   Merckle GmbH Not yet recruiting – verified April 2012

Read More...
« Older Entries